Daijo Inaguma

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 25

Top Topics

Cardiovascular Events

Coronary Artery

Oral Anticoagulants

Top Venues

Clinical and experimental nephrology

Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Daijo Inaguma, Yoshitaka Tatematsu, Naoki Okamoto, Soshiro Ogata, Hideki Kawai, Eiichi Watanabe, Yukio Yuzawa, Midori Hasegawa, Naotake Tsuboi
Multicentre, open-label, randomised, controlled trial to compare early intervention with calcimimetics and conventional therapy in preventing coronary artery calcification in patients with secondary hyperparathyroidism (UPCOMING): a study protocol. BMJ open 14 (1) (2024)
Daijo Inaguma, Yoshitaka Tatematsu, Naoki Okamoto, Soshiro Ogata, Hideki Kawai, Eiichi Watanabe, Yukio Yuzawa, Midori Hasegawa, Naotake Tsuboi
Multicentre, open-label, randomised, controlled trial to compare early intervention with calcimimetics and conventional therapy in preventing coronary artery calcification in patients with secondary hyperparathyroidism (UPCOMING): a study protocol. BMJ open 14 (1) (2024)
Daijo Inaguma, Yoshitaka Tatematsu, Naoki Okamoto, Soshiro Ogata, Hideki Kawai, Eiichi Watanabe, Yukio Yuzawa, Midori Hasegawa, Naotake Tsuboi
Multicentre, open-label, randomised, controlled trial to compare early intervention with calcimimetics and conventional therapy in preventing coronary artery calcification in patients with secondary hyperparathyroidism (UPCOMING): a study protocol. BMJ open 14 (1) (2024)
Daijo Inaguma, Yoshitaka Tatematsu, Naoki Okamoto, Soshiro Ogata, Hideki Kawai, Eiichi Watanabe, Yukio Yuzawa, Midori Hasegawa, Naotake Tsuboi
Multicentre, open-label, randomised, controlled trial to compare early intervention with calcimimetics and conventional therapy in preventing coronary artery calcification in patients with secondary hyperparathyroidism (UPCOMING): a study protocol. BMJ open 14 (1) (2024)
Daijo Inaguma, Fumihiko Koiwa, Masanori Tokumoto, Masafumi Fukagawa, Shinji Yoneda, Hisami Yasuzawa, Kenji Asano, Keiko Hagita, Yosuke Inagaki, Daisuke Honda, Tadao Akizawa
Phase 2 study of upacicalcet in Japanese haemodialysis patients with secondary hyperparathyroidism: an intraindividual dose-adjustment study. Clinical kidney journal 16 (12) (2023)
Yuji Sasakawa, Yoshitaka Tatematsu, Joichiro Kato, Maya Fujii, Naoki Okamoto, Daijo Inaguma
Relationship between serum sodium level at dialysis initiation and all-cause mortality. Clinical and experimental nephrology (2023)
Naoki Okamoto, Daijo Inaguma, Hiroki Hayashi, Akira Koseki, Toshiya Iwamori, Michiharu Kudo, Yukio Yuzawa
Prescription rate of erythropoietin-stimulating agents is low for patients with renal impairment under non-nephrology care in a tertiary-level academic medical center in Japan. Clinical and experimental nephrology 26 (7) (2022)
Daijo Inaguma, Hiroki Hayashi, Ryosuke Yanagiya, Akira Koseki, Toshiya Iwamori, Michiharu Kudo, Shingo Fukuma, Yukio Yuzawa
Development of a machine learning-based prediction model for extremely rapid decline in estimated glomerular filtration rate in patients with chronic kidney disease: a retrospective cohort study using a large data set from a hospital in Japan. BMJ open 12 (6) (2022)
Eri Ito, Daijo Inaguma, Haruka Ishii, Yukio Yuzawa, Daijiro Kabata, Ayumi Shintani, Masaaki Inaba, Masanori Emoto, Katsuhito Mori, Tomoaki Morioka, Shinya Nakatani, Tetsuo Shoji
Associations of time-dependent changes in phosphorus levels with cardiovascular diseases in patients undergoing hemodialysis: results from the Japan Dialysis Active Vitamin D (J-DAVID) randomized clinical trial. Clinical kidney journal 15 (12) (2022)
Eri Koshi-Ito, Daijo Inaguma, Shigehisa Koide, Kazuo Takahashi, Hiroki Hayashi, Naotake Tsuboi, Midori Hasegawa, Shoichi Maruyama, Yukio Yuzawa
Relationship between selection of dosage forms of vitamin D receptor activators and short-term survival of patients on hemodialysis. Renal failure 43 (1) (2022)
Hiroyuki Yoshida, Daijo Inaguma, Eri Ito, Soshiro Ogata, Akimitsu Kitagawa, Kazuo Takahashi, Shigehisa Koide, Hiroki Hayashi, Midori Hasegawa, Yukio Yuzawa, Naotake Tsuboi
Extreme hyperuricemia is a risk factor for infection-related deaths in incident dialysis patients: a multicenter prospective cohort study. Renal failure 42 (1) (2021)
Yukako Ohyama, Hisateru Yamaguchi, Kazuki Nakajima, Tomohiro Mizuno, Yukihiro Fukamachi, Yasuto Yokoi, Naotake Tsuboi, Daijo Inaguma, Midori Hasegawa, Matthew B Renfrow, Jan Novak, Yukio Yuzawa, Kazuo Takahashi
Author Correction: Analysis of O-glycoforms of the IgA1 hinge region by sequential deglycosylation. Scientific reports 11 (1) (2021)
Miho Tatematsu, Daijo Inaguma, Takumi Yamada, Izumi Sakamoto, Masako Sakakibara
The impact of gender difference on the relationship between serum high-density lipoprotein level and cardiovascular events in incident dialysis patients: a multicenter prospective cohort study. International urology and nephrology 52 (7) (2020)
Daijo Inaguma, Akimitsu Kitagawa, Ryosuke Yanagiya, Akira Koseki, Toshiya Iwamori, Michiharu Kudo, Yukio Yuzawa
Increasing tendency of urine protein is a risk factor for rapid eGFR decline in patients with CKD: A machine learning-based prediction model by using a big database. PloS one 15 (9) (2020)
Yukako Ohyama, Hisateru Yamaguchi, Kazuki Nakajima, Tomohiro Mizuno, Yukihiro Fukamachi, Yasuto Yokoi, Naotake Tsuboi, Daijo Inaguma, Midori Hasegawa, Matthew B Renfrow, Jan Novak, Yukio Yuzawa, Kazuo Takahashi
Analysis of O-glycoforms of the IgA1 hinge region by sequential deglycosylation. Scientific reports 10 (1) (2020)
Hikaru Morooka, Akihito Tanaka, Daijo Inaguma, Shoichi Maruyama
Peripheral artery disease at the time of dialysis initiation and mortality: a prospective observational multicenter study. BMJ open 10 (12) (2020)
Daijo Inaguma, Daichi Morii, Daijiro Kabata, Hiroyuki Yoshida, Akihito Tanaka, Eri Koshi-Ito, Kazuo Takahashi, Hiroki Hayashi, Shigehisa Koide, Naotake Tsuboi, Midori Hasegawa, Ayumi Shintani, Yukio Yuzawa
Prediction model for cardiovascular events or all-cause mortality in incident dialysis patients. PloS one 14 (8) (2019)
Akihito Tanaka, Daijo Inaguma, Hibiki Shinjo, Asami Takeda
Incidence rate of atrial fibrillation after dialysis initiation and its relationship with cardiovascular events. Acta cardiologica 74 (6) (2019)
Eri Ito, Kiyomi Koike, Akihito Tanaka, Yu Watanabe, Naoki Kamegai, Hiroya Shimogushi, Hibiki Shinjo, Yasuhiro Otsuka, Daijo Inaguma, Asami Takeda
Effect of Low-Density Lipoprotein Apheresis for Nephrotic Idiopathic Membranous Nephropathy as Initial Induction Therapy. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 23 (6) (2019)
Eri Ito, Daijo Inaguma, Shigehisa Koide, Kazuo Takahashi, Hiroki Hayashi, Midori Hasegawa, Yukio Yuzawa
Effect of combined vitamin D receptor activator and lanthanum carbonate on serum fibroblast growth factor 23 level in predialysis patients (CVD-LAF study): design and method. Clinical and experimental nephrology 22 (6) (2018)
Akiko Owaki, Daijo Inaguma, Isao Aoyama, Shinichiro Inaba, Shigehisa Koide, Eri Ito, Kazuo Takahashi, Hiroki Hayashi, Midori Hasegawa, Yukio Yuzawa, null null
Serum phosphate level at initiation of dialysis is associated with all-cause mortality: a multicenter prospective cohort study. Renal failure 40 (1) (2018)
Daijo Inaguma, Yuji Sasakawa, Noriko Suzuki, Eri Ito, Kazuo Takahashi, Hiroki Hayashi, Shigehisa Koide, Midori Hasegawa, Yukio Yuzawa, null null
Aortic stenosis is a risk factor for all-cause mortality in patients on dialysis: a multicenter prospective cohort analysis. BMC nephrology 19 (1) (2018)
Akihito Tanaka, Daijo Inaguma, Yu Watanabe, Takahiro Mizukawa, Hibiki Shinjo, Kiyomi Koike, Yasuhiro Otsuka, Asami Takeda
Hepatitis B Virus Infection Among Patients With Chronic Kidney Disease Who Attended an Educational Program in Japan. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 22 (6) (2018)
Daijo Inaguma, Eri Ito, Kazuo Takahashi, Hiroki Hayashi, Shigehisa Koide, Midori Hasegawa, Yukio Yuzawa, null null
Impact of high mortality in incident dialysis patients due to hypertensive nephrosclerosis: a multicenter prospective cohort study in Aichi, Japan. Clinical and experimental nephrology 22 (6) (2018)
Maya Fujii, Daijo Inaguma, Shigehisa Koide, Eri Ito, Kazuo Takahashi, Hiroki Hayashi, Naotake Tsuboi, Midori Hasegawa, Yukio Yuzawa
Relationship Between Patterns in Antihypertensive Drugs Medication and Mortality in Incident Dialysis Patients: A Multicenter Prospective Cohort Study. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 23 (4) (2018)